BioSpace News Archive

Completing clinical trials for the patient convenience-enhanced ‘Remsima SC’, the subcutaneous version of Remsima®, to file a Marketing Authorization Application to the European Medicines Agency

Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year.

Zynex, Inc. (OTCQB: ZYXI), An innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, and neurological diagnostics, today announced that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference,

Bristol-Myers Squibb Company (NYSE:BMY) today announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief commercial officer, effective immediately.

BIOplus 2018 will reveal the latest global intelligence in biotech and healthcare developments.

Behavioral health services provider focuses on residential treatment facilities and community-based programs for at-risk and adjudicated youth

Warriors powered through a 20-mile ruck march and motivated each other during a recent Wounded Warrior Project® (WWP) gathering for suicide prevention awareness.

Partnership between two health innovators to open three new Spira Care Centers in Missouri in 2019

Updated timeline for the top line results from the CONDUCT study.

Presented at The European Society of Cardiology and Published in the New England Journal of Medicine.